129728-93-4

Upstream product

• 120596-16-9 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-4-O-(methylsulfonyl)-α-D-glucopyranoside 
• 14146-28-2 benzyl 2-acetamido-3-O-benzyl-2-deoxy-6-O-trityl-α-D-glucopyranoside 
• 55287-49-5 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 
• 38416-14-7 benzyl 2-acetamido-3-O-benzyl-2-deoxy-4-O-mesyl-α-D-glucopyranoside 
• 38416-18-1 benzyl 2-acetamido-3-O-benzyl-2-deoxy-4-O-mesyl-6-O-trityl-α-D-glucopyranoside 
• 553-54-8 lithium benzoate 

Downstream Products

• 129728-94-5 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-4-O-mesyl-α-D-galactopyranoside 
• 115973-74-5 benzyl 2-acetamido-3,6-di-O-benzyl-2,4-dideoxy-4-fluoro-α-D-glucopyranoside 
• 74024-19-4 2-acetamido-1,3,6-tri-O-acetyl-2,4-dideoxy-4-fluoro-α-D-glucopyranose 
• 129728-87-6 2-acetamido-2,4-dideoxy-4-fluoro-α,β-D-glucopyranose 
• 75869-83-9 benzyl 2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-galactopyranoside 

Relevant academic research and scientific papers

Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells

The present invention provides compositions and methods for inhibiting cell migration, e.g., lymphocytes and inflammation. The invention also provides an improved process for preparing fluorinated N-acetylglucosamines.

Fluorinated carbohydrates as potential plasma membrane modifiers. Synthesis of 4- and 6-fluoro derivatives of 2-acetamido-2-deoxy-D-hexopyranoses.

2-Amino-2,4-dideoxy-4-fluoro- and 2-amino-2,4,6-trideoxy-4, 6-difluoro-D-galactose, and 2-amino-2,4-dideoxy-4-fluoro- and 2-amino-4-deoxy-4, 4-difluoro-D-xylo-hexose were synthesized, as potential modifiers of tumor cell-surface glyco-conjugate, from benz